UBS Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $43
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
UBS analyst Joseph Spak initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $43.
UBS analyst Joseph Spak initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $43.